Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

The global metagenomics sequencing market size was US$ 1139.3 million in 2021. The global metagenomics sequencing market is forecast to grow to US$ 3,994.01 million by 2030 by registering a compound ...

The US Food and Drug Administration cleared a number of molecular tests and immunoassays, as well as a clinical chemistry and a cellular deformation test.

Pipettes? Check. Centrifuges? Check. Microplates? Check. Gloves? Check. Salmon sperm DNA? Check. Wait what? There are a ...

Abstract: Conventional microarray-based biosensors can only detect a limited number of organisms, and adding sensor capabilities requires re-engineering of reagents and devices to detect the presence ...

With an estimated more than 10 million cases, India accounts for nearly 20% of the global epilepsy burden. The number of ...

With over a decade of experience architecting and operating large-scale cloud environments across AWS, Azure, and Google ...

Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density microarray patch (HD-MAP) for clinical studies at a biomedical facility in ...

Vaxxas Chair Sarah Meibusch said, "The TGA manufacturing licence marks a significant milestone for Vaxxas as we progress toward commercialising our HD-MAP technology. By reducing cold-chain ...

By comparing clinical cohorts and populations from Singapore and the US, researchers will study infectious diseases, corneal disorders, liver transplant outcomes, diabetes and lung cancer to uncover ...